Skip to main content

Table 2 New and established diagnoses, treatment status at initial visit, and initiation of treatment within one year

From: Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems

Diagnosis

Established Diagnoses (%)

New Diagnoses (%)

Receiving Treatment at Initial Visit (% of established diagnoses)

Treatment Initiated: new and established diagnoses (%)

Psychiatric

78 (46%)

9 (5%)

33 (20%)

44 (77%)

Hepatitis C

62 (37%)

12 (7%)

0 (0%)

2 (3%)

Hypertension

28 (17%)

15 (9%)

10 (36%)

32 (76%)

Hyperlipidemia

9 (5%)

10 (6%)

4 (44%)

14 (74%)

HIV

7 (4%)

0 (0%)

1 (14%)

2 (29%)

Diabetes

4 (2%)

3 (2%)

2 (50%)

5 (71%)

Other

27 (16%)

5 (3%)

19 (11%)

11 (34%)

Total

215 (74%*)

54 (28%*)

69 (32%)

110 (41%)

  1. *Percentage with one or more diagnoses.